Abstract

Hypertension is associated with a prothrombotic and hypercoagulable state. Angiotensin II (AngII) is a key mediator of the thrombotic abnormalities that accompany hypertension. However, the mechanisms that underlie the prothrombotic actions of AngII remain poorly understood. We have previously demonstrated that AngII enhances thrombus development in the microvasculature and that T‐lymphocytes contribute to the AngII‐enhanced microvascular thrombosis. We have examined the role of interleukin‐6 (IL‐6) in the AngII‐enhanced thrombosis response and assessed whether/how the actions of IL‐6 are linked to T‐cells. Thrombus formation in cremaster arterioles was induced using the light/dye endothelial cell injury model. Wild type (WT) mice, IL‐6−/−mice, and immunodeficient Rag‐1−/− injected with T cells from WT or IL‐6−/− mice were infused (14 d) with AngII (1 μg/kg/min). Some AngII infused WT mice were treated (24 hrs before the thrombus formation) with a blocking antibody directed against either the alpha or beta (gp130) chain of the IL‐6 receptor (IL‐6r). We found that IL‐6−/− mice, Rag‐1−/− mice reconstituted with IL‐6−/− (but not WT) T cells, and WT mice treated with either IL‐6r antibody were significantly protected against the prothrombotic actions of chronic AngII administration. These findings link IL‐6 signaling to the T‐cell dependent prothrombotic effects of AngII. (Supported by HL26441)

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.